Medfinder
Back to blog

Updated: January 20, 2026

How to Help Your Patients Find Methocarbamol in Stock: A Provider's Guide

Author

Peter Daggett

Peter Daggett

Methocarbamol blog header image

A practical guide for providers: tools, scripts, and strategies to help your patients locate Methocarbamol in stock and avoid treatment delays caused by pharmacy shortages.

If you've recently prescribed Methocarbamol only to have a patient call back because they can't fill it, you've encountered a problem that's becoming more common. Methocarbamol's supply base has narrowed significantly over the past several years, and patients are increasingly navigating a patchwork of pharmacy availability.

This guide gives you actionable strategies — and a tool to recommend to patients — to minimize treatment delays and get your patients the relief they need.

Why Is Methocarbamol Harder to Find Than It Used to Be?

Methocarbamol is technically available — but from far fewer manufacturers than a decade ago. Par Pharmaceuticals discontinued it in 2018, Virtus in 2019, and the original Robaxin brand (Endo) exited in 2020. The remaining active suppliers are Bayshore, Camber, and Granules. This narrow supplier base means any manufacturing disruption, distribution issue, or demand spike can create localized pharmacy-level shortages.

Your patients who've been calling CVS and Walgreens without success are not alone — and it's not unusual for a major chain to be out of stock while an independent pharmacy nearby has it on the shelf.

Strategy 1: Recommend medfinder to Your Patients

The most time-efficient solution for your patients is medfinder. Your patient provides their medication, dosage, and ZIP code. medfinder then contacts pharmacies in their area to find out which ones have Methocarbamol in stock and can fill the prescription. Results are sent directly to the patient's phone by text.

This is far more efficient than asking a patient in pain to call pharmacies one by one. Consider adding medfinder.com to your patient discharge instructions or including it in after-visit summaries when you prescribe medications known to have availability issues.

Strategy 2: Build in Prescribing Flexibility

One of the most effective things you can do at the point of prescribing is to add dosage flexibility to the prescription. For Methocarbamol, this means noting that either 500 mg or 750 mg tablets are acceptable, with the total daily dose remaining within therapeutic range.

For example, instead of writing strictly "Methocarbamol 500 mg QID," consider noting "Methocarbamol 500 mg QID or 750 mg TID — dispense whichever strength is in stock." This gives the pharmacist the flexibility to use available inventory without a new prescription.

Strategy 3: Send Prescriptions to Independent Pharmacies

When you have a patient in an area where Methocarbamol availability is known to be an issue, consider sending the e-prescription directly to an independent pharmacy rather than a chain pharmacy. Independent pharmacies frequently carry inventory that chain pharmacies don't, and your patient won't waste time going to a pharmacy only to be turned away.

If you're not sure which independent pharmacies are in your patients' neighborhoods, services like medfinder can identify which pharmacies currently have the medication available.

Strategy 4: Have a Backup Prescription Ready

For patients who need immediate relief, consider prescribing a therapeutic alternative at the same visit and instructing the patient to fill whichever one is available. This approach works well in telehealth settings where you can't guarantee pharmacy availability in real time. Common alternatives for acute musculoskeletal conditions include:

Cyclobenzaprine 5-10 mg TID — closest alternative, more sedating, avoid in patients >65 or with cardiac history

Tizanidine 2-4 mg TID — shorter duration, good for flexible dosing, avoid with ciprofloxacin/fluvoxamine

Baclofen 5-10 mg TID — preferred for neurological spasticity, must be tapered

Metaxalone 800 mg TID-QID — least sedating, higher cost, monitor LFTs

Strategy 5: Consider Mail-Order for Patients With Non-Urgent Needs

For patients who need Methocarbamol for a recurring condition (such as chronic episodic muscle spasm) or who can tolerate a short wait, mail-order pharmacies may be the most reliable source. Because Methocarbamol is not a controlled substance, transferring or sending prescriptions to mail-order is straightforward.

Encourage patients to check whether their insurance plan's mail-order pharmacy has Methocarbamol in stock, as mail-order fulfillment centers typically maintain larger inventory buffers than retail pharmacies.

What to Tell Your Patients: A Simple Script

If your patient is heading out to fill a Methocarbamol prescription, consider giving them this brief guidance:

"If your pharmacy is out of Methocarbamol, go to medfinder.com. They can find which pharmacies near you have it in stock."

"Ask about the other strength — if they don't have 500 mg, check if they have 750 mg."

"Try an independent pharmacy — they often have it when chains don't."

"If you can't find it today, call us — we have a backup prescription ready for you."

Telehealth Prescribing: A Note

Methocarbamol is not a controlled substance, which means it can be prescribed via telehealth without the DEA prescribing restrictions that apply to Schedule II-IV drugs. However, telehealth providers face a particular challenge: you cannot verify real-time pharmacy inventory during the visit. Building the habit of prescribing a backup alternative alongside Methocarbamol during telehealth encounters can significantly reduce return calls and delays for patients.

For the full supply status briefing, see our provider-focused post: Methocarbamol Shortage: What Providers Need to Know in 2026.

Frequently Asked Questions

Yes. Providers or their office staff can use medfinder.com to check which pharmacies near a patient's ZIP code have Methocarbamol in stock before sending the prescription. This can prevent the frustrating cycle of a patient being unable to fill their medication and calling back for an alternative.

Yes. Methocarbamol is not a controlled substance, so it does not require in-person evaluation under DEA regulations. It can be prescribed through telehealth visits in all U.S. states without the additional prescribing restrictions that apply to Schedule II-IV drugs.

For most patients with acute musculoskeletal pain, cyclobenzaprine is the closest alternative. Tizanidine is preferred when the patient needs flexible dosing or when cyclobenzaprine's anticholinergic effects are a concern. For patients with neurological spasticity, baclofen is the preferred choice. For patients requiring the least sedation, metaxalone is an option.

Yes. Where clinically appropriate, noting on the prescription that either 500 mg or 750 mg tablets are acceptable can give pharmacists the flexibility to dispense whichever strength is available without requiring a new prescription. This is especially useful in areas where localized supply gaps are known to occur.

Methocarbamol is listed on the AGS Beers Criteria as potentially inappropriate for adults 65 and older due to the risk of CNS depression and falls. If a muscle relaxant is truly necessary for an elderly patient, use the lowest effective dose, counsel on fall risk, and prioritize non-pharmacological approaches (physical therapy, heat/ice, NSAIDs) alongside or instead of pharmacotherapy.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Methocarbamol also looked for:

Cyclobenzaprine (Flexeril)Tizanidine (Zanaflex)Baclofen (Lioresal)Metaxalone (Skelaxin)

30,038 have already found their meds with Medfinder.

Start your search today.

30K+
5-star ratingTrusted by 30,038 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?